AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...

Lefamulin has shown significant activity against gram-positive bacteria ... attainment against key pathogens like Streptococcus pneumoniae and Staphylococcus aureus [4]. This suggests that ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

When complications of pneumonia do develop in the pregnant patient ... Aminoglycosides should only be used if there is evidence of serious gram-negative infection, because the risk of ototoxicity ...

coli, Klebsiella pneumoniae, Pseudomonas aeruginosa ... are losing their ability to fight infections effectively.

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults ...